• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Understanding Biologic Options in Atopic Dermatitis Management


Test your knowledge on approved biologics in the management of moderate to severe atopic dermatitis and considerations for an 18-year-old man's case.

The vast treatment landscape to treat atopic dermatitis (AD) requires transparency and shared decision making with patients. Peter Lio, MD, and April Armstrong, MD, MPH, led a session at the 2023 Fall Clinical Dermatology Conference focusing on the biologic options available.1

titikul_b/Adobe Stock

titikul_b/Adobe Stock

Test your knowledge of the condition, the biologic treatment landscape, and considerations in the case of an 18-year-old man.

What is the prevalence of AD in children and adults?


  1. Armstrong A, Lio P. Closing the Health Care Gaps in the Management of Moderate to Severe Atopic Dermatitis With Biologics. Presented at: 2023 Fall Clinical Dermatology Conference; October 19-22, 2023, Las Vegas, NV.
  2. Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387(10023):1109-1122. doi:10.1016/S0140-6736(15)00149-X
  3. Irvine AD, Mina-Osorio P. Disease trajectories in childhood atopic dermatitis: an update and practitioner's guide. Br J Dermatol. 2019;181(5):895-906. doi:10.1111/bjd.17766
Related Videos
© 2024 MJH Life Sciences

All rights reserved.